• 1. Enabling chloride salts for thermal energy storage: implications of salt purity?
  J. Matthew Kurley,Phillip W. Halstenberg,Abbey McAlister,Stephen Raiman,Richard T. Mayes RSC Adv., 2019,9, 25602-25608
• 2. Fate of nitrogen-15 in the subsequent growing season of greenhouse tomato plants (Lycopersicon esculentum Mill) as influenced by alternate partial root-zone irrigation
  Maomao Hou,Fenglin Zhong,Qiu Jin,Enjiang Liu,Jie Feng,Tengyun Wang,Yue Gao RSC Adv., 2017,7, 34392-34400
• 3. Fe(ii)-Assisted one-pot synthesis of ultra-small core–shell Au–Pt nanoparticles as superior catalysts towards the HER and ORR?
  Yi Cao,Yujiao Xiahou,Lixiang Xing,Xiang Zhang,Hong Li,ChenShou Wu,Haibing Xia Nanoscale, 2020,12, 20456-20466
• 4. Ester-mediated peptide formation promoted by deep eutectic solvents: a facile pathway to proto-peptides?
  Chen-Yu Chien,Sheng-Sheng Yu Chem. Commun., 2020,56, 11949-11952
• 5. Excitation dependent bidirectional electron transfer in phthalocyanine-functionalised MoS2 nanosheets?
  Christopher J. Harrison,Kyle J. Berean,Enrico Della Gaspera,Jian Zhen Ou,Richard B. Kaner,Kourosh Kalantar-zadeh,Torben Daeneke Nanoscale, 2016,8, 16276-16283

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Thiazolecarboxylic acids and derivatives
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Thiazoles Thiazolecarboxylic acids and derivatives

Professional Introduction to 2,4-Dibromo-1,3-thiazole-5-carboxamide (CAS No: 1239506-44-5)

2,4-Dibromo-1,3-thiazole-5-carboxamide, identified by the Chemical Abstracts Service Number (CAS No) 1239506-44-5, is a heterocyclic compound that has garnered significant attention in the field of pharmaceutical chemistry and medicinal biology due to its unique structural properties and potential biological activities. This compound belongs to the thiazole class, a scaffold that is widely recognized for its versatility in drug discovery. The presence of bromine substituents at the 2 and 4 positions, along with a carboxamide functional group at the 5 position, imparts distinct reactivity and interaction capabilities that make it a valuable candidate for further exploration.

The structural framework of 2,4-Dibromo-1,3-thiazole-5-carboxamide consists of a five-membered ring containing sulfur and nitrogen atoms, which is a hallmark of thiazole derivatives. This core structure is highly conducive to forming hydrogen bonds and participating in various non-covalent interactions with biological targets. The bromine atoms at the 2 and 4 positions introduce electrophilic centers, making the molecule susceptible to nucleophilic substitution reactions, which can be exploited in synthetic chemistry for further derivatization. Additionally, the carboxamide group at the 5 position provides a polar moiety that can enhance solubility and binding affinity in biological systems.

In recent years, there has been a surge in research focused on thiazole derivatives due to their demonstrated efficacy in modulating various biological pathways. Specifically, compounds with similar structural motifs have shown promise in inhibiting enzymes and receptors involved in inflammatory responses, microbial infections, and even cancer progression. The brominated thiazole carboxamides, such as 2,4-Dibromo-1,3-thiazole-5-carboxamide, are of particular interest because they combine the bioisosteric properties of bromine with the pharmacophoric features of the thiazole ring. This combination has been observed to enhance binding affinity and metabolic stability in several drug candidates.

One of the most compelling aspects of 2,4-Dibromo-1,3-thiazole-5-carboxamide is its potential as a lead compound for developing novel therapeutic agents. The bromine substituents can serve as handles for further chemical modifications through cross-coupling reactions such as Suzuki or Buchwald-Hartwig couplings, allowing for the introduction of aryl or heteroaryl groups that may improve pharmacokinetic profiles. The carboxamide functionality can also be subjected to amidation or esterification reactions to fine-tune solubility and bioavailability. Such modifications are critical in optimizing drug-like properties and ensuring efficacy in preclinical and clinical settings.

Recent advancements in computational chemistry have enabled researchers to predict the binding modes of 2,4-Dibromo-1,3-thiazole-5-carboxamide with various biological targets with high accuracy. Molecular docking studies have suggested that this compound may interact with proteins involved in DNA replication and transcriptional regulation, which are key mechanisms in cancer cell proliferation. Additionally, preliminary data indicate that it may exhibit antimicrobial activity by disrupting bacterial cell wall synthesis or interfering with essential metabolic pathways. These findings underscore the importance of 2,4-Dibromo-1,3-thiazole-5-carboxamide as a potential candidate for further pharmacological investigation.

The synthesis of 2,4-Dibromo-1,3-thiazole-5-carboxamide involves multi-step organic transformations that highlight the synthetic versatility of thiazole derivatives. A common synthetic route begins with the bromination of a thiourea derivative followed by cyclization to form the thiazole ring. Subsequent functionalization at the 5 position through carboxylation or amidation yields the desired product. The use of modern catalytic systems has improved the efficiency and selectivity of these reactions, making it feasible to produce 1239506-44-5 on a scalable basis for research purposes.

In conclusion,2,4-Dibromo-1,3-thiazole-5-carboxamide represents a promising scaffold for drug discovery with its unique structural features and potential biological activities. The combination of bromine substituents and a carboxamide group provides multiple opportunities for chemical modification and optimization. As research continues to uncover new therapeutic targets and mechanisms,1239506-44-5 is poised to play a significant role in developing next-generation pharmaceuticals. Its potential applications span across oncology,microbiologyand inflammation research ,making it an exciting area for further exploration by academic scientistsand pharmaceutical industry professionals alike.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)